Your Regulatory Impact Assessment Agent for Turning Change into Action Watch Ria in Action
August 2026The European Medicines Agency (EMA) has issued guidance for pharmaceutical companies participating in a pilot programme that supports reliance-based submission of post-authorisation changes to multiple non-EU markets at the same time.
Region: EU Harmonized (27 Markets)
Reach out to us and let’s unravel your Regulatory puzzle together. Unlock regulatory solutions with our global subject matter experts and tap into a wealth of regulatory intelligence.
Speak to an Expert
